Skip to content

Docs (opens in a new tab)Pricing Ideas Benchmark

Sign in Sign up

A

ACIU

AC Immune SA

NASDAQHealthcareBiotechnologyCH

NASDAQ · Healthcare · Biotechnology · CH

$2.63

−1.87%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsIdeas

Research · Sep 3, 2026
ACIU: FY25 Deep Dive
AC Immune FY25 at CHF 4M. NI CHF -67M; EPS CHF -0.67.

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Workspace|Docs (opens in a new tab)|Pricing|Research|Methodology|Privacy|Disclaimer|Contact|© 2026 LIL GREBE INC.